A recently approved treatment was supposed to protect babies from RSV, but demand is outpacing the supply of the medication. The antibody is not a treatment for RSV, since it works to prevent ...

Every winter Primary Children's Hospital fills with infants and toddlers suffering from Respiratory Syncytial Virus, known as RSV. But for the first time, many or even most of those hospitalizations ...

NEW YORK CITY -- In September, an 8-month-old baby came into Dr. Juanita Mora's office in Chicago with an infection the doctor hadn't expected to see for another two months: RSV. Like her peers across ...

The Centers for Disease Control and Prevention (CDC) has issued a health alert that the antibody treatment used to protect infants from respiratory syncytial virus (RSV) is in short supply. The alert ...

An injectable treatment that gives immediate protection against RSV is in short supply, which is especially concerning for parents of babies. An injectable treatment that gives immediate protection ...

As the United States heads into the colder weather months, cases of respiratory syncytial virus (RSV) have been ticking up across the country. For the week ending Nov. 25, there were 8,863 positive ...

A preventive treatment for lower respiratory tract infections caused by RSV got the go ahead from the European Commission on Friday, according to one of the companies that make it. The treatment is ...

The pharmaceutical giant could emerge as a new competitor in the market for treatments against RSV, which causes thousands of deaths among older Americans and hundreds of deaths among infants each ...

Medical experts discuss current obstacles facing ideal respiratory syncytial virus (RSV) treatment strategies in children. Adam C. Welch, PharmD, MBA, FAPhA: I want to shift over now to [Kimberly C.